Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...
1 Department of Endocrinology and Diabetology, University Medical Center Maribor, Maribor, Slovenia 2 Faculty of Medicine, University of Maribor, Maribor, Slovenia Introduction: Basal insulin with ...
Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...
Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...
Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback